Sana M. Al‐Khatib

  • Citations Per Year
Learn More
A trial fibrillation (AF) is a global health problem. The condition brings an increased risk of stroke, systemic embolism, and heart failure (HF) and is associated with impaired quality of life, frequent hospitalizations, and mortality. Observational studies have been the main source of information for many years and have defined the clinical presentation,(More)
BACKGROUND Prior studies have demonstrated a link between the metabolic syndrome and increased risk of cardiovascular mortality. Whether the metabolic syndrome is associated with sudden cardiac death is uncertain. METHODS AND RESULTS We characterized the relationship between sudden cardiac death and metabolic syndrome status among participants of the ARIC(More)
  • 1